THE SMART TRICK OF AML RISK SCORE THAT NO ONE IS DISCUSSING

In spite of achieving a complete reaction with optimum induction therapy, minimum residual disease generally persists, necessitating consolidation therapy to mitigate the risk of relapse by eliminating residual ailment. In individuals who have gained seven+3 induction therapy, consolidation therapy is initiated with large-dose cytarabine, often kn